Skip to main content
Back to Accel

Accel's Pharmaceutical Portfolio

Browse 10 Pharmaceutical companies funded by Accel. See funding amounts, founder contacts, and investment details.

Pharmaceutical Companies
10
Total Funding in Pharmaceutical
$116.7M

Pharmaceutical Portfolio Companies (10)

Export
BiopharmaBiotechnologyGeneticsMedicalPharmaceuticalTherapeutics

Arctic Therapeutics is a drug discovery and development company that focuses on identifying genetic causes of major diseases.

Reykjavík, Iceland
October 2026
$21.5M
Venture - Series Unknown

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareLife SciencePharmaceutical

Pentixapharm develop PentixaFor and PentixaTher as a theranostic radiopharmaceutical pair.

Würzburg, Germany
July 2026
$23.2M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Artificial Intelligence (AI)PharmaceuticalSoftware

AI agents to accelerate clinical development workflows for the pharma industry.

New York, United States
July 2026
$3.0M
Seed

Founder Contacts

41,000+ verified contacts

Advanced MaterialsArtificial Intelligence (AI)BiopharmaBiotechnologyData IntegrationEnterprise SoftwareHealth DiagnosticsPharmaceuticalSoftware

Perceptic develops modular AI software that supports scientific decision-making for biopharma research and external asset evaluation.

London, United Kingdom
May 2026
$12.0M
Seed

Founder Contacts

41,000+ verified contacts

MedicalOncologyPharmaceuticalPrecision Medicine

Casinvent Pharma develops therapeutic options for the treatment of selected malignancies.

Brno, Czech Republic
April 2026
Grant

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyPharmaceutical

DIANA Biotechnologies specializes in the development of products based on research in clinical diagnostics and drug discovery areas.

Vestec, Czech Republic
April 2026
Grant

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareMedical DevicePharmaceuticalTherapeutics

Click Therapeutics develops and commercializes software as prescription medical treatments designed to address unmet healthcare needs.

New York, United States
April 2026
$50.0M
Series D

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyHealth CareLife SciencePharmaceutical

Monument Therapeutics used digital biomarkers to develop innovative new drugs for neuropsychiatric disorders including schizophrenia

Cambridge, United Kingdom
February 2026
Venture - Series Unknown

Founder Contacts

41,000+ verified contacts

ManufacturingPharmaceutical

​Reacta Biotech is develop, manufacture and commercialise oral food challenge materials to pharmaceutical standards.

Manchester, United Kingdom
November 2025
$3.7M
Venture - Series Unknown

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CarePharmaceutical

SiVEC Biotechnologies is a bio technology company.

Fort Collins, United States
September 2025
$3.3M
Seed

Founder Contacts

41,000+ verified contacts

Explore Accel's Full Portfolio

View all companies funded by Accel across every industry and funding stage.

View Full Accel Portfolio